|
|
Volumn 24, Issue 3, 2006, Pages 229-
|
|
Diversa restructures, raising question over bioprospecting
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
ATORVASTATIN;
PHYTASE;
VACCINE;
XYLAN ENDO 1,3 BETA XYLOSIDASE;
BIOTECHNOLOGY;
DRUG DESIGN;
DRUG INDUSTRY;
ENERGY RESOURCE;
INDUSTRY;
MARKETING;
NOTE;
ORGANIZATION;
PAPER INDUSTRY;
PATENT;
POLLUTION CONTROL;
PRIORITY JOURNAL;
BIOTECHNOLOGY;
CAPITAL FINANCING;
ENTREPRENEURSHIP;
INDUSTRY;
INVESTMENTS;
MARKETING;
OWNERSHIP;
UNITED STATES;
|
|
EID: 33644871443
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0306-229 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
